How This One AI Stock Became My Obsession

Broadcom reported Q1 fiscal 2026 AI semiconductor revenue of $8.40B, up 106% year over year, and guided Q2 AI revenue to $10.70B. Management said it has line of sight to more than $100B of AI chip revenue in 2027, with supply secured through 2028, while Q1 free cash flow reached $8B and the company returned capital via $7.8B of buybacks and a 10% dividend increase to $0.65 per share. The article is highly bullish on Broadcom’s AI moat and cash-generation profile despite noting customer concentration and valuation risk.

Analysis

Broadcom is increasingly a toll booth on AI capex rather than a normal semiconductor cyclical: the economic value is shifting from generic GPU supply to customized, sticky infrastructure where switching costs rise every quarter. That matters because the next leg of upside is likely to come less from unit growth and more from pricing power, attach rates, and longer-duration software monetization around the same customer base. The second-order beneficiary is AVGO’s supply chain and contract manufacturing ecosystem, but the bigger implication is that hyperscalers are outsourcing more architectural control than they would like, which makes Broadcom harder to displace even if buyers push back on cost.

The market is probably still underappreciating how much of AVGO’s earnings durability now comes from multi-year budget commitments rather than one-off AI bursts. If the company truly has visibility three to four years out, the biggest risk is not a near-term demand air pocket but a delayed capex pause that shows up first in order cadence, then in guidance compression, then in multiple contraction. In other words, the stock is vulnerable to a sentiment shock before a fundamentals shock; that gap can be weeks to months, while the underlying revenue stream may remain intact for years.

The contrarian issue is that consensus may be extrapolating “AI infrastructure winner” too mechanically into a permanent premium multiple, when the real question is whether the current growth rate can persist after the first wave of buildouts normalizes. If hyperscalers reach a point where they are optimizing utilization rather than adding capacity, AVGO’s growth decelerates but the valuation may still be priced for scarcity. META matters indirectly here: any moderation in its AI spend would not just hurt one line item, it would test the thesis that multiple end customers can offset concentration risk fast enough to protect the narrative.

From a portfolio perspective, this is a high-conviction compounder, but the cleaner expression is not an outright momentum chase. The better setup is to own AVGO on pullbacks while hedging factor risk with a short in a broader semi basket or an equal-weight tech hedge, because the main drawdown scenario is multiple compression, not a collapse in cash generation. The entry matters: buying after weak guidance or post-rally consolidation improves asymmetry materially versus paying up into a consensus victory lap.

Key Decisions for Investors

• Long AVGO on 3-5% pullbacks with a 6-12 month horizon; target a rerating on sustained AI backlog visibility, but expect 15-20% drawdowns if the market reprices the multiple rather than the earnings stream.
• Pair trade: long AVGO / short SOXX or a broad semiconductor ETF for 3-6 months; this isolates the name-specific moat and capital-return story while hedging against sector-wide AI multiple compression.
• If already long AVGO, buy downside protection via 3-6 month put spreads around the next earnings cycle; the highest-probability risk is a guidance-reset-driven gap, not a slow fundamental fade.
• Use META as a monitoring hedge: if META capex or AI commentary weakens, trim AVGO exposure tactically because hyperscaler spending moderation would hit the concentration thesis first.
• For new capital, stage entries in thirds rather than full size; the stock has enough quality to own, but the forward multiple leaves limited room for mistake if AI enthusiasm cools over the next 1-2 quarters.